# China NMPA Drug Inspection - Shenyang Guancheng Pharmaceutical Co., Ltd. - Amlodipine besylate tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shenyang-guancheng-pharmaceutical-co-ltd/c7b54c98-63f1-4a20-8402-c4445e982b75/
Source feed: China

> China NMPA drug inspection for Shenyang Guancheng Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amlodipine besylate tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Shenyang Guancheng Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amlodipine besylate tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/shenyang-guancheng-pharmaceutical-co-ltd/d1f5efb7-2ee2-4f17-b549-ce29d966d010/